Open Access Repository

Echocardiographic feature of diabetic cardiomyopathy: Where are we now?

Downloads

Downloads per month over past year

Negishi, K ORCID: 0000-0002-9086-2565 2018 , 'Echocardiographic feature of diabetic cardiomyopathy: Where are we now?' , Cardiovascular Diagnosis and Therapy, vol. 8, no. 1 , pp. 47-56 , doi: 10.21037/cdt.2018.01.03.

[img] PDF
125456 Journal ...pdf | Request a copy
Full text restricted

Abstract

We are now entering the very exciting era of treatment and management of diabetes mellitus (DM) with the emergence of new therapeutic agents, including sodium-glucose cotransporter 2 inhibitors (SGLT2i) and dipeptidyl peptidase-4 inhibitor (DPP-4i). From a cardiology and echocardiography perspective, the existence of diabetic cardiomyopathy has been proven through over four decades of discussion. DM is highly prevalent in patients with heart failure (HF). Independent associations are found after adjusting for hypertension (HTN) and coronary artery disease (CAD). In patients with both DM and HF, the prognosis is extremely dismal. In this review, the main focus is on both diabetic cardiomyopathy per se and its typical features (including myocardial additive insult related to DM), diagnosis, and management.

Item Type: Article
Authors/Creators:Negishi, K
Keywords: diabetes mellitus (DM), diabetic cardiomyopathy, echocardiography, myocardial strain, sodium-glucose cotransporter 2 inhibitors (SGLT2i)
Journal or Publication Title: Cardiovascular Diagnosis and Therapy
Publisher: AME Publishing Company
ISSN: 2223-3652
DOI / ID Number: 10.21037/cdt.2018.01.03
Copyright Information:

© Cardiovascular Diagnosis and Therapy. All rights reserved.

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP